Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 2
1(14.3%)
7Total
N/A(6)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)